✦ LIBER ✦

Interstitial pneumonia induced by combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma

✍ Scribed by Shinji Yamamoto; Yasuhiko Tomita; Yoshihiko Hoshida; Norishige Iizuka; Shigeru Marubashi; Atsushi Miyamoto; Hiroaki Nagano; Keizo Dono; Koji Umeshita; Shoji Nakamori; Masato Sakon; Katsuyuki Aozasa; Morito Monden

Publisher: Springer Japan
Year: 2004
Tongue: English
Weight: 301 KB
Volume: 39
Category: Article
ISSN: 0944-1174
DOI: 10.1007/s00535-004-1375-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined intraarterial 5-fluorouracil an

Combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches

✍ Masato Sakon; Hiroaki Nagano; Keizo Dono; Shoji Nakamori; Koji Umeshita; Akira Y 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 417 KB

Combination therapy of intraarterial 5-f

Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion

✍ Shuntaro Obi; Haruhiko Yoshida; Risa Toune; Tadao Unuma; Miho Kanda; Shinpei Sat 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 207 KB

Combination therapy of intra-arterial 5-

Combination therapy of intra-arterial 5-fluorouracil and systemic pegylated interferon α-2b for advanced hepatocellular carcinoma

✍ Kazuhiro Kasai; Akira Ushio; Yukiho Kasai; Kei Sawara; Yasuhiro Miyamoto; Kanta 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 379 KB

Pretreatment predictor of response, time

Pretreatment predictor of response, time to progression, and survival to intraarterial 5-fluorouracil/interferon combination therapy in patients with advanced hepatocellular carcinoma

✍ Kiminori Uka; Hiroshi Aikata; Shintaro Takaki; Daiki Miki; Tomokazu Kawaoka; Soo 📂 Article 📅 2007 🏛 Springer Japan 🌐 English ⚖ 199 KB

Successful treatment of multiple hepatoc

Successful treatment of multiple hepatocellular carcinoma with tumor thrombi in the major portal branches by intraarterial 5-fluorouracil perfusion chemotherapy combined with subcutaneous interferon-alpha and hepatectomy

✍ Tameyoshi Yamamoto; Hiroaki Nagano; Yasuharu Imai; Kazuto Fukuda; Hitoshi Matsum 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 521 KB

Interferon-α and 5-fluorouracil combinat

Interferon-α and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules

✍ Hiroaki Nagano; Atsushi Miyamoto; Hiroshi Wada; Hideo Ota; Shigeru Marubashi; Yu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB

## Abstract ## BACKGROUND. The authors reported previously the beneficial effects of interferon (IFN)‐α/5‐fluorouracil (5‐FU) combination therapy for patients with advanced hepatocellular carcinoma (HCC) who have tumor thrombi in the major portal branches. In this report, the authors describe the